Shopping Cart 0
Cart Subtotal
AED 0

U.S. Stem Cell Inc (USRM) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 1376

Details

U.S. Stem Cell Inc (USRM)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

U.S. Stem Cell Inc (U.S. Stem Cell), formerly Bioheart, Inc, is a biotechnology company that focuses on the discovery, development and commercialization of cell based therapeutics products. The company's lead product MyoCell is an autologous muscle stem cell therapy for improving cardiac functions of a patient with serious, chronic heart damage due to heart attack. Its other lead product is MyoCell SDF-1, an improvement of MyoCell for similar applications; AdipoCell, a proprietary kit used for the isolation of adipose (fat) derived stem cells. The company provides laboratory services, regenerative medicine and cell therapy training services, and operates a cell therapy clinic. The company primarily operates in the US and sales its products to non-US countries as well. U.S. Stem Cell is headquartered in Sunrise, Florida, the US.

U.S. Stem Cell Inc Key Recent Developments

Aug 07,2019: USRM posts earnings for second quarter 2019

Jun 04,2019: Federal court issues decision holding that US Stem Cell clinics and owner adulterated and misbranded stem cell products in violation of the law

May 07,2019: USRM posts financial results for first quarter 2019

Apr 26,2019: Dr. Comella to present at Paleo f(x) Conference in Austin, Texas

Mar 13,2019: USRM posts increase in revenue and profit margin for 2018

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

U.S. Stem Cell Inc-Key Facts

U.S. Stem Cell Inc-Key Employees

U.S. Stem Cell Inc-Key Employee Biographies

U.S. Stem Cell Inc-Major Products and Services

U.S. Stem Cell Inc-History

U.S. Stem Cell Inc-Company Statement

U.S. Stem Cell Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2-Company Analysis

Company Overview

U.S. Stem Cell Inc-Business Description

U.S. Stem Cell Inc-Corporate Strategy

U.S. Stem Cell Inc-SWOT Analysis

SWOT Analysis-Overview

U.S. Stem Cell Inc-Strengths

U.S. Stem Cell Inc-Weaknesses

U.S. Stem Cell Inc-Opportunities

U.S. Stem Cell Inc-Threats

U.S. Stem Cell Inc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's, Lifesciences Financial Deals and Alliances

U.S. Stem Cell Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

U.S. Stem Cell Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

U.S. Stem Cell Inc, Recent Deals Summary

Section 5-Company's Recent Developments

Aug 07, 2019: USRM posts earnings for second quarter 2019

Jun 04, 2019: Federal court issues decision holding that US Stem Cell clinics and owner adulterated and misbranded stem cell products in violation of the law

May 07, 2019: USRM posts financial results for first quarter 2019

Apr 26, 2019: Dr. Comella to present at Paleo f(x) Conference in Austin, Texas

Mar 13, 2019: USRM posts increase in revenue and profit margin for 2018

Jan 15, 2019: USRM chief science officer featured on One Radio Network

Dec 06, 2018: USRM announces U.S. Stem Cell Clinic Expansion of Products and Services

Nov 07, 2018: USRM posts 25% nine month revenue increase from 3Q 2017

Sep 11, 2018: USRM hires senior VP of US & international sales

Aug 08, 2018: USRM posts profitable results for second quarter 2018

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

U.S. Stem Cell Inc, Performance Chart (2014-2018)

U.S. Stem Cell Inc, Ratio Charts

U.S. Stem Cell Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

U.S. Stem Cell Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

U.S. Stem Cell Inc, Key Facts

U.S. Stem Cell Inc, Key Employees

U.S. Stem Cell Inc, Key Employee Biographies

U.S. Stem Cell Inc, Major Products and Services

U.S. Stem Cell Inc, History

U.S. Stem Cell Inc, Joint Venture

U.S. Stem Cell Inc, Key Competitors

U.S. Stem Cell Inc, Ratios based on current share price

U.S. Stem Cell Inc, Annual Ratios

U.S. Stem Cell Inc, Annual Ratios (Cont...1)

U.S. Stem Cell Inc, Interim Ratios

U.S. Stem Cell Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

U.S. Stem Cell Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

U.S. Stem Cell Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

U.S. Stem Cell Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

St. Jude Medical LLC

Medtronic Plc

Edwards Lifesciences Corp

Corindus Vascular Robotics Inc

Cesca Therapeutics Inc

Company Profile

Company Profile Title

U.S. Stem Cell Inc (USRM)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

U.S. Stem Cell Inc (U.S. Stem Cell), formerly Bioheart, Inc, is a biotechnology company that focuses on the discovery, development and commercialization of cell based therapeutics products. The company's lead product MyoCell is an autologous muscle stem cell therapy for improving cardiac functions of a patient with serious, chronic heart damage due to heart attack. Its other lead product is MyoCell SDF-1, an improvement of MyoCell for similar applications; AdipoCell, a proprietary kit used for the isolation of adipose (fat) derived stem cells. The company provides laboratory services, regenerative medicine and cell therapy training services, and operates a cell therapy clinic. The company primarily operates in the US and sales its products to non-US countries as well. U.S. Stem Cell is headquartered in Sunrise, Florida, the US.

U.S. Stem Cell Inc Key Recent Developments

Aug 07,2019: USRM posts earnings for second quarter 2019

Jun 04,2019: Federal court issues decision holding that US Stem Cell clinics and owner adulterated and misbranded stem cell products in violation of the law

May 07,2019: USRM posts financial results for first quarter 2019

Apr 26,2019: Dr. Comella to present at Paleo f(x) Conference in Austin, Texas

Mar 13,2019: USRM posts increase in revenue and profit margin for 2018

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

U.S. Stem Cell Inc-Key Facts

U.S. Stem Cell Inc-Key Employees

U.S. Stem Cell Inc-Key Employee Biographies

U.S. Stem Cell Inc-Major Products and Services

U.S. Stem Cell Inc-History

U.S. Stem Cell Inc-Company Statement

U.S. Stem Cell Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2-Company Analysis

Company Overview

U.S. Stem Cell Inc-Business Description

U.S. Stem Cell Inc-Corporate Strategy

U.S. Stem Cell Inc-SWOT Analysis

SWOT Analysis-Overview

U.S. Stem Cell Inc-Strengths

U.S. Stem Cell Inc-Weaknesses

U.S. Stem Cell Inc-Opportunities

U.S. Stem Cell Inc-Threats

U.S. Stem Cell Inc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's, Lifesciences Financial Deals and Alliances

U.S. Stem Cell Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

U.S. Stem Cell Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

U.S. Stem Cell Inc, Recent Deals Summary

Section 5-Company's Recent Developments

Aug 07, 2019: USRM posts earnings for second quarter 2019

Jun 04, 2019: Federal court issues decision holding that US Stem Cell clinics and owner adulterated and misbranded stem cell products in violation of the law

May 07, 2019: USRM posts financial results for first quarter 2019

Apr 26, 2019: Dr. Comella to present at Paleo f(x) Conference in Austin, Texas

Mar 13, 2019: USRM posts increase in revenue and profit margin for 2018

Jan 15, 2019: USRM chief science officer featured on One Radio Network

Dec 06, 2018: USRM announces U.S. Stem Cell Clinic Expansion of Products and Services

Nov 07, 2018: USRM posts 25% nine month revenue increase from 3Q 2017

Sep 11, 2018: USRM hires senior VP of US & international sales

Aug 08, 2018: USRM posts profitable results for second quarter 2018

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

U.S. Stem Cell Inc, Performance Chart (2014-2018)

U.S. Stem Cell Inc, Ratio Charts

U.S. Stem Cell Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

U.S. Stem Cell Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

U.S. Stem Cell Inc, Key Facts

U.S. Stem Cell Inc, Key Employees

U.S. Stem Cell Inc, Key Employee Biographies

U.S. Stem Cell Inc, Major Products and Services

U.S. Stem Cell Inc, History

U.S. Stem Cell Inc, Joint Venture

U.S. Stem Cell Inc, Key Competitors

U.S. Stem Cell Inc, Ratios based on current share price

U.S. Stem Cell Inc, Annual Ratios

U.S. Stem Cell Inc, Annual Ratios (Cont...1)

U.S. Stem Cell Inc, Interim Ratios

U.S. Stem Cell Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

U.S. Stem Cell Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

U.S. Stem Cell Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

U.S. Stem Cell Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

St. Jude Medical LLC

Medtronic Plc

Edwards Lifesciences Corp

Corindus Vascular Robotics Inc

Cesca Therapeutics Inc